Cite
Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan.
MLA
Hsu, C.‐S., et al. “Interferon-Based Therapy Reduces Risk of Stroke in Chronic Hepatitis C Patients: A Population-Based Cohort Study in Taiwan.” Alimentary Pharmacology & Therapeutics, vol. 38, no. 4, Aug. 2013, pp. 415–23. EBSCOhost, https://doi.org/10.1111/apt.12391.
APA
Hsu, C. ‐S., Kao, J. ‐H., Chao, Y. ‐C., Lin, H. H., Fan, Y. ‐C., Huang, C. ‐J., & Tsai, P. ‐S. (2013). Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan. Alimentary Pharmacology & Therapeutics, 38(4), 415–423. https://doi.org/10.1111/apt.12391
Chicago
Hsu, C.‐S., J.‐H. Kao, Y.‐C. Chao, H. H. Lin, Y.‐C. Fan, C.‐J. Huang, and P.‐S. Tsai. 2013. “Interferon-Based Therapy Reduces Risk of Stroke in Chronic Hepatitis C Patients: A Population-Based Cohort Study in Taiwan.” Alimentary Pharmacology & Therapeutics 38 (4): 415–23. doi:10.1111/apt.12391.